ASN
KYMR icon

Advisory Services Network’s Kymera Therapeutics KYMR Stock Holding History

Advisory Services Network’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58K Buy
+19
New +$1.5K ﹤0.01% 4197
2025
Q4 		– Sell
-13
Closed -$736 – 3188
2025
Q3 		$736 Buy
+13
New +$586 ﹤0.01% 3996

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Advisory Services Network's KYMR Position: Q1 2026 in Review

Advisory Services Network opened a new position in Kymera Therapeutics (KYMR) in Q1 2026: 19 shares worth $1.58K. The stake represents ﹤0.01% of the portfolio and ranks #4197 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in KYMR as recently as Q3 2025.

Advisory Services Network first reported a position in KYMR in Q3 2025 and has held it in 2 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Advisory Services Network held 19 shares of Kymera Therapeutics worth $1.58K as of Q1 2026.
  • Kymera Therapeutics was a new Advisory Services Network position in Q1 2026.
  • Kymera Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4197 holding.
  • Advisory Services Network first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.